NASA Official Hopeful

WASHINGTON—The pam of the present will eventually lead to longterm gains for space scientists if NASA’s budget continues to grow, says Lennard A. Fisk, the agency’s new associate administrator for space science and applications. “NASA has essentially been directed by the president to go back to its R&D roots, and that will do well for science and applications,” Fisk told THE SCIENTIST in one of his first interviews since taking the position in April. “If I

Written byTony Reichhardt
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—The pam of the present will eventually lead to longterm gains for space scientists if NASA’s budget continues to grow, says Lennard A. Fisk, the agency’s new associate administrator for space science and applications.

“NASA has essentially been directed by the president to go back to its R&D roots, and that will do well for science and applications,” Fisk told THE SCIENTIST in one of his first interviews since taking the position in April. “If I stand back from the short-term, day-to-day problems, the long-term trends are very healthy.”

Fisk’s immediate concern is bridging the gap between the present launch hiatus and the mid1990s, when the space station and additional Delta expendable launchers are expected to become available for science payloads. As a near-term solution, NASA plans to use upgraded Scout rockets to provide flight opportunities in the early 1990s for small (up to 475 pounds) experiments in astrophysics, space ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies